Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-12

FDA Approved: THYROGEN — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for THYROGEN (thyrotropin alfa) from Genzyme Corporation, updating the labeling to support its use in diagnostic and tre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thyrogen (thyrotropin alfa)

Snippet

SUPPL AP for THYROGEN (THYROTROPIN ALFA)